|
Q4 2023
|
1 |
2,120 |
STRM
|
13F-HR
|
2/8/2024 |
000109544924000013 |
|
Q3 2023
|
21 |
154,421 |
SPY Nov3 400.0 P puts, BDX Oct3 275.0 C calls, DXCM Oct3 110.0C calls, VTRS
|
13F-HR
|
11/15/2023 |
000109544923000090 |
|
Q2 2023
|
35 |
323,565 |
SPY puts, TLT calls, VTRS, MDRX
|
13F-HR
|
8/9/2023 |
000109544923000075 |
|
Q1 2023
|
39 |
273,602 |
QQQ 1Ap3 295.0 P puts, SPY Apr3 370.0 P puts, RSP Apr3 155.0 C calls, VTRS
|
13F-HR
|
5/10/2023 |
000109544923000047 |
|
Q4 2022
|
36 |
194,194 |
QQQ Jan3 270.0 P puts, MDRX, VTRS, SPY Jan3 380.0 P puts
|
13F-HR
|
2/13/2023 |
000109544923000030 |
|
Q3 2022
|
46 |
170,318 |
LNTH, MDRX, PCRX, PRGO
|
13F-HR
|
11/14/2022 |
000109544922000115 |
|
Q2 2022
|
41 |
172,848 |
CI, LNTH, CERS, PCRX
|
13F-HR
|
8/15/2022 |
000109544922000089 |
|
Q1 2022
|
49 |
211,350 |
CI, PCRX, LNTH, MRK
|
13F-HR
|
5/11/2022 |
000109544922000043 |
|
Q4 2021
|
48 |
243,211 |
THC, PCRX, MDT, BVS
|
13F-HR
|
2/14/2022 |
000109544922000014 |
|
Q3 2021
|
45 |
316,702 |
HSIC, RIGL, MDT, PCRX
|
13F-HR
|
11/12/2021 |
000109544921000099 |
|
Q2 2021
|
53 |
353,037 |
MDT, RIGL, HSIC, PCRX
|
13F-HR
|
8/13/2021 |
000109544921000075 |
|
Q1 2021
|
76 |
487,518 |
PCRX, MDT, RIGL, PDCO
|
13F-HR
|
5/11/2021 |
000109544921000041 |
|
Q4 2020
|
46 |
479,955 |
PCRX, MDT, UTHR, RIGL
|
13F-HR
|
2/10/2021 |
000109544921000015 |
|
Q3 2020
|
36 |
324,480 |
PCRX, MDT, HOLX, PRGO
|
13F-HR
|
11/12/2020 |
000109544920000053 |
|
Q2 2020
|
33 |
359,176 |
PCRX, DGX, PRGO, UTHR
|
13F-HR
|
8/11/2020 |
000109544920000050 |
|
Q1 2020
|
31 |
264,078 |
DGX, MDT, ATRC, MDRX
|
13F-HR
|
5/14/2020 |
000109544920000031 |
|
Q4 2019
|
29 |
437,664 |
MDT, BIO, MDRX, ATRC
|
13F-HR
|
2/11/2020 |
000109544920000011 |
|
Q3 2019
|
32 |
383,785 |
MDRX, MDT, BIO, PCRX
|
13F-HR
|
11/5/2019 |
000109544919000068 |
|
Q2 2019
|
22 |
328,883 |
MDRX, MDT, BIO, PCRX
|
13F-HR
|
8/12/2019 |
000109544919000050 |
|
Q1 2019
|
22 |
251,884 |
MDRX, MDT, SRCL, PTLA
|
13F-HR
|
5/13/2019 |
000109544919000029 |
|
Q4 2018
|
21 |
245,232 |
MDRX, MDT, NUVA, NOVOCURE LTD
|
13F-HR
|
2/11/2019 |
000109544919000007 |
|
Q3 2018
|
32 |
350,230 |
NUVA, NOVOCURE LTD, LH, MDRX
|
13F-HR
|
11/13/2018 |
000109544918000097 |
|
Q2 2018
|
28 |
298,741 |
NOVOCURE LTD, MDT, NUVA, MDRX
|
13F-HR
|
8/14/2018 |
000109544918000066 |
|
Q1 2018
|
28 |
210,233 |
NVCR, NUVA, MDRX, MDT
|
13F-HR
|
5/8/2018 |
000109544918000031 |
|
Q4 2017
|
32 |
183,207 |
NOVOCURE LTD, MDRX, PCRX, LH
|
13F-HR
|
2/14/2018 |
000109544918000014 |
|
Q3 2017
|
33 |
163,323 |
MDRX, NOVOCURE LTD, NKTR, MDT
|
13F-HR
|
11/13/2017 |
000109544917000111 |
|
Q2 2017
|
38 |
171,312 |
MDRX, NOVOCURE LTD, NKTR, LH
|
13F-HR
|
8/8/2017 |
000109544917000083 |
|
Q1 2017
|
31 |
160,058 |
MDRX, PCRX, NKTR, GILD
|
13F-HR
|
5/12/2017 |
000109544917000058 |
|
Q4 2016
|
27 |
141,372 |
ARIA, NXSTAGE MEDICAL INC, HOLX, BIO
|
RESTATEMENT
|
2/16/2017 |
000109544917000026 |
|
Q3 2016
|
38 |
317,913 |
ELGXQ, NXSTAGE MEDICAL INC, PDCO, ARIA
|
NEW HOLDINGS
|
11/10/2016 |
000109544916000302 |
|
Q3 2016
|
38 |
317,913 |
ELGXQ, NXSTAGE MEDICAL INC, PDCO, ARIA
|
13F-HR
|
11/9/2016 |
000109544916000301 |
|
Q2 2016
|
28 |
260,704 |
ELGXQ, NXSTAGE MEDICAL INC, IMPR, ARIA
|
13F-HR
|
8/15/2016 |
000109544916000274 |
|
Q1 2016
|
21 |
285,699 |
ELGXQ, DGX, PDCO, NXSTAGE MEDICAL INC
|
13F-HR
|
5/16/2016 |
000109544916000245 |
|
Q4 2015
|
31 |
759,795 |
SPY puts, TLT calls, PDCO, DGX
|
13F-HR
|
2/8/2016 |
000109544916000188 |